Scarica l'app Stockscreener
125.45
4.02%
4.85
Pre-mercato:
125.78
0.33
+0.26%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Merck Co Inc Borsa (MRK) Ultime notizie
Qualcomm, Merck, Rockwell Automation: CNBC’s ‘Final Trades’Qualcomm (NASDAQ:QCOM), Simon Property Grou - Benzinga
Merck & Co. lifts 2026 outlook, Keytruda and vaccines drive shares on Wall Street - Ad-hoc-news.de
Merck & Co., Inc. Shs Unsponsored Brazilian Depository Receipt Repr 0.125 Sh - TradingView
Enterprise value to revenue forward of Merck & Co., Inc. – HAN:6MK - TradingView
Merck & Co. updates pipeline and oncology focus, shares stay in the S&P 500 spotlight - Ad-hoc-news.de
Merck & Co Inc Stock (MRK) Moved Up by 4.04% on Jun 25: A Full Analysis - TradingKey
Gilead's Trodelvy Expands Reach With New FDA Approval In Breast Cancer - Benzinga
Merck & Co., Inc. Actuals & Estimates (NYSE:MRK) - TradingView
Price to sales forward of Merck & Co., Inc. – HAN:6MK - TradingView
Merck & Co. updates late-stage cancer pipeline, shares on NYSE radar - Ad-hoc-news.de
Merck (MRK) Stock Gets New Outperform Rating from CICC - Insider Monkey
Global HPV Vaccines Market to Grow Rapidly at a CAGR of ~8% by 2034 | DelveInsight - GlobeNewswire Inc.
Is Merck & Co., Inc. (MRK) Strengthening Its Vaccine Portfolio With New Capvaxive Approval? - Insider Monkey
CICC Initiates Merck & Co. at Outperform With $138 Price Target - marketscreener.com
THRIVENT HEALTHCARE PORTFOLIO's Merck & Co Inc(MRK) Holding History - GuruFocus
Merck & Co. clears a short-term technical mark, shares extend their recent advance - Ad-hoc-news.de
Is Merck & Co Inc (MRK) Overvalued After 3.6% Rally? GF Value Sa - GuruFocus
Merck & Co Inc Stock (MRK) Moved Up by 3.23% on Jun 23: Key Drivers Unveiled - TradingKey
Merck's Anti-TL1A Antibody Meets Goal in Ulcerative Colitis Study - Yahoo Finance Singapore
Merck & Co. Inc. stock outperforms competitors on strong trading day - MarketWatch
Merck & Co. outlines strategic pipeline moves, shares hold steady on NYSE - AD HOC NEWS
Merck Scores Key Phase 3 Win For Novel Ulcerative Colitis Therapy - Benzinga
Merck’s Oncology Engine Is Still Accelerating (NYSE:MRK) - Seeking Alpha
Merck & Co. eyes oncology and vaccine strategy, shares tracked against big pharma peers - AD HOC NEWS
Merck’s Tulisokibart Met Primary and Key Secondary Endpoints in the Phase 3 ATLAS-UC Induction-only Study in Patients With Moderately to Severely Active Ulcerative Colitis (UC) - Business Wire
Berenberg Adjusts Price Target on Merck & Co. to $125 From $115, Maintains Hold Rating - marketscreener.com
Why Merck (MRK) Is Using KEYTRUDA and WELIREG to Deepen Its Kidney Cancer Franchise - Insider Monkey
Merck & Co. Stockweekly review and pharma peer comparison - AD HOC NEWS
Penn Series Large Core Value Fund's Merck & Co Inc(MRK) Holding History - GuruFocus
symbol__ Stock Quote Price and Forecast - CNN
LVIP MFS Value Fund's Merck & Co Inc(MRK) Holding History - GuruFocus
Is Merck's Recent Restructuring a Confident Pivot or a Defensive Maneuver - Kavout | AI
Merck & Co., Inc. Sued for Securities Law ViolationsInvestors - The National Law Review
Merck & Co. Inc. stock outperforms competitors despite losses on the day - MarketWatch
FDA Expands Merck Pneumococcal Shot Label To Include At-Risk Children And Teens - Benzinga
Merck granted U.S. label expansion for Capvaxive pneumococcal shot - Seeking Alpha
Merck's pneumococcal vaccine wins US approval for high-risk children, teens - Reuters
Merck & Co., Inc. (MRK) Insider Trading Activity 2026 $MRK - MarketBeat
Here’s Why Merck (MRK) is Among the 10 Undervalued Counter Cyclical Stocks to Buy Now - Insider Monkey
WRIGHT INVESTORS SERVICE INC's Merck & Co Inc(MRK) Holding History - GuruFocus
JPMorgan Growth Advantage Fund's Merck & Co Inc(MRK) Holding History - GuruFocus
A Look at Merck & Co Inc (MRK) After 3.5% Decline -- GF Value $1 - GuruFocus
Merck & Co. Inc. stock underperforms Monday when compared to competitors - MarketWatch
Merck & Co Inc Stock (MRK) Moved Down by 3.13% on Jun 15: What Signal Does It Send? - TradingKey
Panagora Asset Management Inc. Purchases 567,249 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Acquired by Resources Management Corp CT ADV - MarketBeat
Vanguard Personalized Indexing Management LLC Grows Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
MFS Value Fund's Merck & Co Inc(MRK) Holding History - GuruFocus
Perryman Financial Advisory Inc. AD Makes New Investment in Merck & Co., Inc. $MRK - MarketBeat
Mariner LLC Has $289.84 Million Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Kennedy Capital Management LLC Sells 16,448 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Evelyn Partners Investment Management LLP - MarketBeat
Merck & Co., Inc.: - marketscreener.com
Merck & Co. Inc. Stock (US58933Y1055): Valuation and fundamentals in focus after steady trading - AD HOC NEWS
Gross margin % of Merck & Co., Inc. Shs Cert Deposito Arg Repr 1/5 Sh – BCBA:MRK.CI - TradingView
Focus Partners Wealth Has $149.61 Million Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Total common shares outstanding of Merck & Co., Inc. Shs Cert Deposito Arg Repr 1/5 Sh – BCBA:MRK.CI - TradingView
Enterprise value to EBITDA ratio of Merck & Co., Inc. Shs Cert Deposito Arg Repr 1/5 Sh – BCBA:MRK.CI - TradingView
Current ratio of Merck & Co., Inc. Shs Cert Deposito Arg Repr 1/5 Sh – BCBA:MRK.CI - TradingView
Huber Capital Management LLC Buys 10,000 Shares of Merck & Co., Inc. $MRK - MarketBeat
LM Advisors LLC Reduces Holdings in Merck & Co., Inc. $MRK - MarketBeat
Epoch Investment Partners Inc. Grows Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Arax Advisory Partners Has $30.94 Million Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Brown Advisory Inc. Purchases 36,941 Shares of Merck & Co., Inc. $MRK - MarketBeat
Bollard Group LLC Has $13.90 Million Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
INVESCO V.I. Health Care Fund's Merck & Co Inc(MRK) Holding History - GuruFocus
Merck & Co. Inc. Stock (US58933Y1055): Insider and institutional ownership in focus - AD HOC NEWS
1.31%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):